KRS Global Biotechnology, a Boca Raton, Fla.-based drug compounding facility, is recalling all lots of its unexpired human and animal drugs due to lack of sterility assurance.
Pharmacy
Despite the new "right-to-try" law, many drugmakers still want a relevant regulatory authority to review requests from patients with life-threatening illnesses who want access to experimental drugs, according to a recent Government Accountability Office report.
Though several Big Pharma companies face a federal opioid trial next month, several have reached settlements that may allow them a sizable tax break, according to USA Today.
CVS Health agreed to pay $4.4 million to settle a lawsuit accusing it of exposing the HIV status of roughly 4,500 Ohio patients, according to The Columbus Dispatch.
The owner of a New York City pharmacy has been charged with allegedly leading an opioid distribution ring and committing healthcare fraud, according to ABC 7.
The FDA is warning patients and healthcare providers that some ranitidine medicines, common heartburn drugs, contain a potentially cancer-causing impurity.
The University of Washington School of Pharmacy in Seattle will partner with biopharmaceutical company UCB to improve patient access to epilepsy treatment and care, according to Medical Xpress.
A new study released Sept. 11 explains why so many cancer drugs don't make it past clinical trials, according to STAT.
Ten hospitals and health systems that posted job listings seeking pharmacy leadership in the last week.
Sprout Pharmaceuticals has revoked its Sept. 4 news release claiming the FDA eased restrictions on its controversial female libido pill, according to STAT.